Literature DB >> 20117697

Primary posterior capsulotomy using a 25-gauge vitreous cutter in vitrectomy combined with cataract surgery.

Shimpei Sato1, Maiko Inoue, Satoshi Kobayashi, Yoichiro Watanabe, Kazuaki Kadonosono.   

Abstract

We describe a primary posterior capsulotomy technique using a 25-gauge vitreous cutter to prevent postoperative posterior capsule opacification (PCO) in patients with vitreoretinal diseases who must have a vitrectomy combined with cataract surgery. Following phacoemulsification, a 25-gauge vitrectomy, and intraocular lens implantation in the capsular bag, the posterior capsule is removed via a pars plana approach using a 25-gauge vitreous cutter; the removed capsule is round, well centered, and approximately 5.0 mm in diameter. This technique prevents postoperative PCO completely, improving vision and enabling detailed examination of the fundus after surgery. Copyright 2010 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20117697     DOI: 10.1016/j.jcrs.2009.07.049

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  4 in total

1.  Primary surgical posterior capsulotomy during phacovitrectomy.

Authors:  P Alexander; A J Luff
Journal:  Eye (Lond)       Date:  2015-01-09       Impact factor: 3.775

2.  Clinical Outcomes of Primary Posterior Continuous Curvilinear Capsulorhexis in Postvitrectomy Cataract Eyes.

Authors:  Mengting Yu; Duan Yan; Wenjie Wu; Yingbin Wang; Xinna Wu
Journal:  J Ophthalmol       Date:  2020-07-30       Impact factor: 1.909

3.  Efficacy and safety of primary posterior capsulotomy in combined phaco-vitrectomy in rhegmatogenous retinal detachment.

Authors:  Kyung-Sup Shin; Hye-Jin Park; Young-Joon Jo; Jung-Yeul Kim
Journal:  PLoS One       Date:  2019-03-08       Impact factor: 3.240

4.  Efficacy and safety of primary posterior capsulotomy during phaco-vitrectomy for epiretinal membrane.

Authors:  Ki Won Jin; Se Joon Woo; Kyu Hyung Park
Journal:  BMC Ophthalmol       Date:  2022-01-03       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.